A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome

NCT02139033 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca

Interventions

DRUG: Retaine™

Sponsor

Ocusoft, Inc.

Collaborators

[object Object]